SAR442970 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12-17 in 1mo
ESTIMATED |
READOUT
A Study to Investigate the Efficacy and Safety of Brivekimig in Adult Participan
Phase 2 · Ulcerative Colitis |
SNY Sanofi | SAR442970 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
|